p53 regulates the mitochondrial immune checkpoint

Claire Vanpouille-Box1, Lorenzo Galluzzi2

  • 1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Center, New York, NY, USA.

Trends in Immunology
|March 18, 2023
PubMed

Insights

Tumor protein p53 regulates mitochondrial outer membrane permeabilization (MOMP) and type I interferon production. It also directs mitochondrial DNA (mtDNA)-degrading enzymes for proteasomal processing, impacting immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Mitochondrial outer membrane permeabilization (MOMP) is essential for releasing mitochondrial DNA (mtDNA) into the cytosol.
  • Cytosolic mtDNA activates innate and adaptive immune responses.
  • The role of tumor protein p53 in regulating these processes is under investigation.

Purpose of the Study:

  • To investigate the role of tumor protein p53 in regulating MOMP-dependent type I interferon (IFN) production.
  • To elucidate the mechanisms by which p53 influences mtDNA release and degradation.

Main Methods:

  • The study likely involved experiments assessing MOMP, type I IFN production, and mtDNA levels in cells with varying p53 status.
  • Methods may include Western blotting, ELISA, quantitative PCR, and nuclease assays.
  • Proteasomal degradation pathways were likely investigated.

Main Results:

  • Tumor protein p53 was found to regulate MOMP, influencing type I IFN production.
  • p53 also directs mtDNA-degrading exonucleases towards proteasomal degradation.
  • These dual functions of p53 impact the immune response initiated by mtDNA.

Conclusions:

  • Tumor protein p53 plays a multifaceted role in immunity by controlling both MOMP and mtDNA degradation.
  • p53's regulation of mtDNA processing is crucial for fine-tuning immune signaling.
  • These findings offer new insights into the interplay between mitochondria, p53, and the immune system.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K